“revolution-medicines” Archives

in
Entry Author Date Location
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug 06/05/20 New York
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer 02/12/20 San Francisco
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers 01/17/20 San Francisco
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Ginkgo Eyes Antibiotics With Deal for Warp Drive’s Gene “Mining” Tech 05/15/19 Boston
In Search of Names, Tech Startups Look to Galaxies Far, Far Away 11/08/18 Boston
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
Warp Drive’s Odyssey Ends with a Buyout—By Revolution, Not Sanofi 10/16/18 San Francisco
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More 04/27/18 National
Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer 04/24/18 San Francisco
REVOLUTION Medicines Garners $25,000,000 Series A Funding 12/22/16 San Francisco
Former Cubist CEO Mike Bonney Joins Third Rock Ventures 01/07/16 Boston
West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon 02/06/15 San Diego
REVOLUTION Medicines Receives $45,000,000 Series A Financing 02/05/15 San Francisco
Third Rock’s New Revolution Looks to Squeeze More Drugs From Nature 02/04/15 San Francisco
Page 1 of 1